As of 11:22 am, the issue received bids for 23,96,082 shares, amounting to 18% of its total offering of 1,34,32,533 shares. The retail portion was subscribed to 32%, while qualified institutional buyers (QIBs) had not placed any bids.

The quota for retail investors was subscribed 0.44 times shares of the allotted quota, while the portion set aside for non-institutional investors was subscribed 12 percent.

Suraksha Diagnostic IPO continues to receive a flat response after Day 2 of public subscription. The public offer is set to open for its final day of bidding on December 3; shares are expected to be listed on Friday,

Suraksha Diagnostic IPO 2024 Live Updates GMP Listing Date time IPO Allotment Listing Review: The company raised a sum of Rs 253.87 crore from anchor investors by selling them 5.75 million shares.

Suraksha Diagnostic IPO, which opened for public subscription on Friday, November 29, 2024, is set to conclude on Tuesday, December 3, 2024

Suraksha Diagnostic IPO received 25% subscription on day 2, with Retail Investors showing strong interest. The IPO, worth Rs 846 crore, concludes on December 3.

Investors in all categories responded ambivalently to the Suraksha Diagnostic IPO on Monday, December 2, the second day of bidding. Only 20 per cent of the mainboard issue has been booked thus far. Out of the 1.34 crore shares available, investors from all categories applied for over 26.32 lakh shares.

While Suraksha Diagnostic's revenue growth over the past few years has remained muted, the company's margins have expanded from 28% in fiscal 2022 to 32% in fiscal 2024. The company's net profit has grown at a 5.4% compounded annual growth rate over FY22-24.

Ahead of the IPO opening, Suraksha Diagnostic raised ₹253.87 crore from 12 institutional investors, including, Nippon Life India, Kotak Mutal Fund, Aditya Birla Sun Life Trustee, and Quant Mutual Fund,

The public issue will close for subscription on December 3, while the trading in equity shares will commence on the bourses, effective December 6.